News

MSK Innovation Hub and IgniteData project signals substantive move away from laborious data transcription in cancer studies.

Data mapping in clinical trials ensures that data taken from sites' EHR are transferred to a sponsor's EDC in a way that is accepted and recognised.

The time is truly ripe for us to realise the many benefits that can come from streamlining the transfer of EHR data into clinical trials – also known as EHR-to-EDC.

Suki Balendra PhD talks through the UK clinical trial landscape from the viewpoint and priorities of the government, the NIHR, research sites & industry.

Qin Ye, a principal at ZS, tells us more about his background, and shares insights on trends, innovation in life sciences and the outlook for clinical trial data.

EHR-to-EDC – where data in a hospital EHR system is transferred directly into the EDC – is the form of eSource exciting the clinical trial research community.

The pharma industry, med tech sector, public health agencies, health insurance, health ministries, and a number of other bodies, are desperate for high quality data.

"The opportunity for direct use of eSource data in clinical trials - via better interoperability between systems - can no longer be ignored"

IgniteData is delighted to announce its membership of the influential HL7 FHIR Vulcan Accelerator programme for clinical trial optimisation

The story of why we wanted to fix the lack of interoperability in clinical trial systems is simple - because it was blindingly obvious that it needed to be done.